Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS

Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS

Polycystic ovary syndrome (PCOS) is characterized by elevated androgen production and subclinical changes in cardiovascular and metabolic risk markers. Total cholesterol, high-density lipoprotein (HDL) cholesterol, fasting glucose, and fasting insulin appear to increase specifically in PCOS compared...

Full description

Bibliographic Details
Main Authors: Andrea Cignarella, Roberto Mioni, Chiara Sabbadin, Francesca Dassie, Matteo Parolin, Roberto Vettor, Mattia Barbot, Carla Scaroni
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:International Journal of Molecular Sciences
Subjects:
biomarkers
anti-androgens
hypoglycemic agents
combined oral contraceptives
statins
Online Access:https://www.mdpi.com/1422-0067/21/24/9554

Internet

https://www.mdpi.com/1422-0067/21/24/9554

Similar Items